Sequential Intravenous-Oral Therapy for Pediatric Streptococcus anginosus Intracranial Infections
- PMID: 35028336
- PMCID: PMC8753039
- DOI: 10.1093/ofid/ofab628
Sequential Intravenous-Oral Therapy for Pediatric Streptococcus anginosus Intracranial Infections
Abstract
Background: Streptococcus anginosus group is a common cause of pediatric intracranial infections but treatment recommendations, including use of oral therapy, are poorly defined.
Methods: We performed a retrospective review from 2004 to 2019 of all patients with S anginosus group pyogenic intracranial infections at Children's Hospital Colorado, highlighting patients transitioned to oral therapy. The primary endpoint was worsening infection necessitating intravenous antibiotics or a source control procedure after transition to oral therapy.
Results: Of 107 patients with S anginosus intracranial infections, 61 were transitioned to exclusive oral therapy after a median intravenous duration of 37 days, overwhelmingly with a levofloxacin-based regimen. Only 1 treatment failure was noted in a patient who did not fill their prescription. Patients with epidural infections were more likely to be transitioned to oral therapy within the first 28 days of treatment (defined as "early"). Patients with parenchymal infections, bacteremia, co-pathogens, higher inflammatory markers, and requiring >1 source control procedure were less likely to be transitioned early to oral therapy. Complications of a central catheter and/or intravenous medications contributed to 56% of oral transitions.
Conclusions: Levofloxacin-based oral regimens were effective and well tolerated. Patients with less severe infections were more likely to be transitioned early to oral therapy. Criteria for transitioning patients to oral antibiotics for intracranial infections should be established to minimize risks inherent with central catheters.
Keywords: Streptococcus anginosus; intracranial infection; levofloxacin; oral therapy.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
References
-
- Widdrington JD, Bond H, Schwab U, et al. . Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome. Infection 2018; 46:785–92. - PubMed
-
- Brouwer MC, van de Beek D.. Epidemiology, diagnosis, and treatment of brain abscesses. Curr Opin Infect Dis 2017; 30:129–34. - PubMed
-
- Brouwer MC, Coutinho JM, van de Beek D.. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology 2014; 82:806–13. - PubMed
-
- Mulvey CL, Kiell EP, Rizzi MD, Buzi A.. The microbiology of complicated acute sinusitis among pediatric patients: a case series. Otolaryngol Head Neck Surg 2019; 160:712–9. - PubMed
-
- Miah MS, Nix P, Koukkoullis A, Sandoe J.. Microbial causes of complicated acute bacterial rhinosinusitis and implications for empirical antimicrobial therapy. J Laryngol Otol 2016; 130:169–75. - PubMed
